Details for tablet - Finpecia 1mg (Finasteride 1mg)
10% EXTRA PILLS ON ORDER OF US $ 99/- OR ABOVE
15% EXTRA PILLS ON REPEAT ORDERS
Finpecia 1mg 10 Tablets/Strip (Generic Propecia)
Manufactured in the Cipla Goa Facility
Finpecia is a product for men that can prevent further hairloss and increase hair growth. The active ingredient Finasteride, blocks the formation of DHT (one of the male hormones that causes hairloss), and gives the hair follicles a chance to recover and grow.
Dosage and administration
Take one tablet daily, with or without meals.
In general use, the following have been reported infrequently: allergic reactions including rash, itching, hives and swelling of the lips and face, problems with ejaculation, breast tenderness and enlargement, and testicular pain. A small number of men experienced certain sexual side effects. These men reported one or more of the following: less desire for sex; difficulty in achieving an erection; and, a decrease in the amount of semen. Each of these side effects occurred in less than 2% of men.
Results vary from person to person. Finpecia lowers readings of the PSA screening test for prostate cancer. If you're scheduled to have your PSA level checked, make sure the physician knows you're taking Finpecia. It may take several months for the Finpecia to work. Do not stop taking this medicine without checking with your physician. Stopping this medicine will result in a return within 12 months to the same amount of baldness as when you started. Women who are or may potentially be pregnant must not use Finpecia and should not handle crushed or broken tablets of Finpecia. If a woman who is pregnant with a male baby absorbs the active ingredient in Finpecia, either by swallowing or through the skin, it may cause abnormalities of a male babys sex organs.
Finpecia is made in India. Even though it contains the exact same chemical as Propecia (1mg of finasteride), its cost is significantly less than that of Propecia.
Cipla is allowed by Indian patent law to make drugs that are patented by other companies internationally as the law protects only the processes by which drugs are made, and not the drugs themselves.
Under current Indian law, which recognizes patents on ways to make drugs but not the drugs themselves.
This means Indian companies can make drugs under patent in the West, provided they use a process that is different from the original.
Manufacturers are able to produce and sell medicines here at a tiny fraction of the prices charged in the United States. In some cases, though, the generic makers have been blocked from selling their wares in other developing countries that have Western-style patent laws.